Larson, Steven M.; Carrasquillo, Jorge A.; Cheung, Nai-Kong V.; Press, Oliver W. (22 May 2015). "Radioimmunotherapy of human ... Seidl, Christof (April 2014). "Radioimmunotherapy with α-particle-emitting radionuclides". Immunotherapy. 6 (4): 431-458. doi: ...
Mausner, Leonard F. (1993). "Selection of radionuclides for radioimmunotherapy". Medical Physics. 20 (2): 503-509. Bibcode: ...
Sharkey, Robert M.; Goldenberg, David M. (2006-01-01). "Advances in Radioimmunotherapy in the Age of Molecular Engineering and ... "Pretargeted radioimmunotherapy of cancer: progress step by step". Journal of Nuclear Medicine. 44 (3): 400-411. ISSN 0161-5505 ... in the mid-1980s a strategy called pretargeted radioimmunotherapy was developed. In short, this approach contained two ... "Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy". ...
Seidl, C (2014). "Radioimmunotherapy with α-particle-emitting radionuclides". Immunotherapy. 6 (4): 431-58. doi:10.2217/imt. ...
Chinol M, Hnatowich DJ (September 1987). "Generator-produced yttrium-90 for radioimmunotherapy". Journal of Nuclear Medicine. ...
In pretargeted radioimmunotherapy, two or three medications are applied in succession. At first, an antibody-drug conjugate is ... It is used experimentally in pretargeted radioimmunotherapy. Animal studies have been conducted as well as clinical studies in ... Domingo RJ; Reilly RM (2000). "Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using ... May 2011). "Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival ...
"Integrin-αvβ3 Targeted Radioimmunotherapy of Glioblastoma Multiforme". Clinical Cancer Research. 14 (22): 7330-9. doi:10.1158/ ...
When the conjugates include a radioisotope see radioimmunotherapy. When the conjugates include a toxin see immunotoxin. ...
Radioimmunotherapy of metastatic melanoma is currently under investigation. Radiotherapy has a role in the palliation of ...
"Production of actinium-225 for alpha particle mediated radioimmunotherapy". Applied Radiation and Isotopes. 62 (5): 667-679. ...
Factors influencing the effect of radioimmunotherapy on liver cancer. Chinese Journal of Cancer Research 4(2):55-60, 1992, ...
Tositumomab, an alternative radioimmunotherapy treatment for non-Hodgkin's lymphoma. Official Zevalin site "Ibritumomab ... WHO Drug Information Schaefer NG, Huang P, Buchanan JW, Wahl RL (May 2011). "Radioimmunotherapy in non-Hodgkin lymphoma: ... Developed by the IDEC Pharmaceuticals, now part of Biogen Idec, ibritumomab tiuxetan was the first radioimmunotherapy drug ... Grillo-López AJ (October 2002). "Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma". Expert Review ...
Davies, A J (28 May 2007). "Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I131 tositumomab". Oncogene. ...
Wu C, Brechbiel MW, Kozak RW, Gansow OA (1994). "Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and ...
There are newer[when?] variations on monoclonal antibodies combined with radioactive molecules known as radioimmunotherapy (RIT ... radioimmunotherapy and new biologic agents. The phases of treatment are generally: frontline, following diagnosis, ...
Alternatively, in radioimmunotherapy a radioactive dose localizes a target cell line, delivering lethal chemical doses. More ... Radioimmunotherapy (RIT) involves the use of radioactively-conjugated murine antibodies against cellular antigens. Most ...
"Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian ...
October 2003). "Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer ...
"Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma". ...
Bolla, Rose A.; Malkemus, D.; Mirzadeh, S. (2005). "Production of actinium-225 for alpha particle mediated radioimmunotherapy ...
July 2005). "Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized ...
Domingo, R. J.; Reilly, R. M. (2000). "Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using ...
... integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts". Cancer ...
These medications were the first agents of what is known as radioimmunotherapy, and they were approved for the treatment of ...
These include: ofatumumab, a monoclonal antibody that is stronger than rituximab in binding to CD20; two radioimmunotherapy ...
... radioimmunotherapy MeSH E02.095.682.884 - tissue therapy MeSH E02.120.285.570 - leukapheresis MeSH E02.120.285.790 - ...
... as a radioimmunotherapy agent, and in combination with chemotherapy. Establishment of the autologous typing system as the ...
... and radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin) & 131I tositumomab (Bexxar) therapy of low-grade non-Hodgkin's ...
... radioimmunotherapy - radioisotope - radiolabeled - radiologic exam - radionuclide scanning - radiopharmaceutical - ...
Radioimmunotherapy and Imaging Advances in Synthesis and Coordination Chemistry of Porphyrins, Phthalocyanines and Related ...